Health system buyers, investors and analysts check LinkedIn before they take a call. For most HealthTech leaders that page is a job title with a headshot. We turn it into the reason the meeting happens.
Hi Founder,
What LinkedIn has produced for HealthTech executives we work with:
▋
A buyer spends on your profile before deciding whether to take the call.
Vendor due diligence starts on LinkedIn before anyone reaches out.
Ghostwritten posts a week, each approved by you before it publishes.
When health system buyers and investors start messaging you, the power dynamic shifts. You are no longer pitching; you are qualifying.
Posts stay searchable. Work published in month two is still producing introductions in month nine, which is why this is the primary channel.
The headline states a job title, so the reader learns your funding round and nothing about your point of view on the market.
The About section reads as a résumé written for an investor deck that no longer applies.
There is no recent activity, so a health system buyer checking you before a demo has nothing to react to.
The few posts that exist are announcements: raises closed, hires made, conferences attended.
Everything is accurate and nothing is distinctive, so the introduction goes to the founder who is easier to quote.
Ninety minutes on the phone. We map the category argument you are actually making, which buying committees and investors you want in the room, and the claims you are willing to defend in public. Everything downstream comes from this call.
Headline, About, featured section, experience entries and banner rewritten as a positioning asset. Written so that a health system CMIO, a growth investor and a trade journalist each find the sentence that matters to them within eight seconds.
A running set of themes you own, mapped to a monthly calendar. Two to five posts a week: commercial judgement applied to procurement and reimbursement questions, commentary on where the category is actually moving, and first person accounts only an operator building the thing could write.
We draft, you approve. Either we generate from what is trending in your category and write it in your position and voice, or we work from voice notes, board decks and product notes you already have. Nothing publishes without your sign off.
Comments and connection activity aimed at a named list: the health system buyers, investors, analysts and journalists who move deals forward. Visibility with the wrong audience is noise. This is the part most founders skip and it is the part that converts.
Monthly report on reach, profile views, search appearances, follower quality and, most importantly, inbound pipeline conversations. We drop what does not move those numbers and double the themes that do.
One 60 minute call a month, plus roughly 20 minutes a week approving drafts from your phone.
If you want follower count as the outcome, we are the wrong firm. We optimise for who is reading, not how many.
Headline read CEO and Co-founder at a named company. Roughly 800 followers, last post nine months old, no inbound from health systems.
Repositioned around what breaks when clinical AI meets a hospital's actual workflow, published three times a week on reimbursement, integration cost and where vendors overpromise.
Grew to 14,300 followers and closed two enterprise pilots sourced directly from inbound within 90 days.
Yes. Every engagement starts with a voice interview, and we work either from what is trending in your category written in your position, or from material you record and send us. You approve every draft before it publishes, and the first month is deliberately slow while we calibrate.
One call. We review your current position, tell you honestly whether LinkedIn is the right channel for you, and show you the first three moves.